| Package | hl7.cda.uv.ips |
| Resource Type | ValueSet |
| Id | 2.16.840.1.113883.11.22.62--20180207120421 |
| FHIR Version | R4 |
| Source | http://hl7.org/cda/uv/cda-ips/https://build.fhir.org/ig/HL7/CDA-IPS/ValueSet-2.16.840.1.113883.11.22.62--20180207120421.html |
| URL | http://art-decor.org/fhir/ValueSet/2.16.840.1.113883.11.22.62--20180207120421 |
| Version | 1.1.0-ballot |
| Status | draft |
| Date | 2024-08-19T09:46:05+00:00 |
| Name | IPSAllergyVerificationStatus |
| Title | IPS Allergy Verification Status |
| Realm | uv |
| Authority | hl7 |
| Description | IPS Allergy Verification Status |
| StructureDefinition | |
| 2.16.840.1.113883.10.22.10--20180207120044 | IPS Allergy Certainty Observation |
No resources found
Note: links and images are rebased to the (stated) source
Generated Narrative: ValueSet 2.16.840.1.113883.11.22.62--20180207120421
Information Source: https://art-decor.org/ad/#/hl7ips-/terminology/valueset
Profile: Shareable ValueSet
Tag: 4.0.1 (Details: FHIRVersion code 4.0.1 = ' 4.0.1 ', stated as ' null ')
http://hl7.org/fhir/ValueSet/request-priority| Code | Display | Comments |
| unconfirmed | Unconfirmed | Note: There is not sufficient diagnostic and/or clinical evidence to treat this as a confirmed condition. |
| confirmed | Confirmed | Note: A high level of certainty about the propensity for a reaction to the identified substance, which may include clinical evidence by testing or rechallenge. |
| refuted | Refuted | Note: A propensity for a reaction to the identified substance has been disproven with a high level of clinical certainty, which may include testing or rechallenge, and is refuted. |
{
"resourceType": "ValueSet",
"id": "2.16.840.1.113883.11.22.62--20180207120421",
"meta": {
"source": "https://art-decor.org/ad/#/hl7ips-/terminology/valueset",
"profile": [
"http://hl7.org/fhir/StructureDefinition/shareablevalueset"
],
"tag": [
{
"system": "http://hl7.org/fhir/FHIR-version",
"code": "4.0.1"
}
]
},
"text": {
"status": "extensions",
"div": "<!-- snip (see above) -->"
},
"extension": [
{
"url": "http://hl7.org/fhir/StructureDefinition/resource-effectivePeriod",
"valuePeriod": {
"start": "2018-02-07T12:04:21+02:00"
}
}
],
"url": "http://art-decor.org/fhir/ValueSet/2.16.840.1.113883.11.22.62--20180207120421",
"identifier": [
{
"use": "official",
"system": "urn:ietf:rfc:3986",
"value": "urn:oid:2.16.840.1.113883.11.22.62"
}
],
"version": "1.1.0-ballot",
"name": "IPSAllergyVerificationStatus",
"title": "IPS Allergy Verification Status",
"status": "draft",
"experimental": false,
"date": "2024-08-19T09:46:05+00:00",
"publisher": "Health Level Seven",
"contact": [
{
"name": "HL7 International - International Patient Summary",
"telecom": [
{
"system": "url",
"value": "http://www.hl7.org/Special/committees/structure"
}
]
}
],
"description": "IPS Allergy Verification Status",
"immutable": false,
"compose": {
"include": [
{
"system": "http://hl7.org/fhir/ValueSet/request-priority",
"concept": [
{
"extension": [
{
"url": "http://hl7.org/fhir/StructureDefinition/valueset-concept-comments",
"valueString": "There is not sufficient diagnostic and/or clinical evidence to treat this as a confirmed condition."
}
],
"code": "unconfirmed",
"display": "Unconfirmed"
},
{
"extension": [
{
"url": "http://hl7.org/fhir/StructureDefinition/valueset-concept-comments",
"valueString": "A high level of certainty about the propensity for a reaction to the identified substance, which may include clinical evidence by testing or rechallenge."
}
],
"code": "confirmed",
"display": "Confirmed"
},
{
"extension": [
{
"url": "http://hl7.org/fhir/StructureDefinition/valueset-concept-comments",
"valueString": "A propensity for a reaction to the identified substance has been disproven with a high level of clinical certainty, which may include testing or rechallenge, and is refuted."
}
],
"code": "refuted",
"display": "Refuted"
}
]
}
]
}
}